Boswellia (AKBA) Research Guide

Full name: Boswellia Serrata Extract (AKBA)

A standardized extract of Boswellia serrata (frankincense) whose active constituent AKBA provides a non-NSAID anti-inflammatory pathway. Biohackers use it for joint pain, gut inflammation, and as a natural alternative to chronic NSAID use.

How Boswellia (AKBA) Works

AKBA (acetyl-11-keto-beta-boswellic acid) selectively inhibits 5-lipoxygenase (5-LOX), reducing pro-inflammatory leukotrienes. This targets a different inflammatory pathway than NSAIDs (which act on COX), sparing the stomach lining.

Dosing Protocol

• Typical dose: 100-250 mg AKBA-standardized, 1-2x daily
• Frequency: 1-2x daily
• Duration: Ongoing
• Route: Oral capsule

Reported Benefits

• Reduces joint pain and stiffness
• Non-NSAID (stomach-sparing) anti-inflammatory
• Supports gut inflammation (IBD research)
• Cartilage protection
• Anti-inflammatory via 5-LOX inhibition

Potential Side Effects

• Mild GI upset
• Nausea
• Rare skin rash
• Possible additive effect with anti-inflammatories

Research Citations

1. Boswellia AKBA for osteoarthritis (2020) - AKBA-standardized extract significantly reduced pain and improved joint function versus placebo over 3 months.
2. Boswellia in inflammatory bowel disease (2019) - Reduced inflammatory markers and symptoms in colitis models via 5-LOX inhibition.

Related Pain & Inflammation Compounds

• Low-Dose Naltrexone (LDN) - Full Profile
• PEA - Full Profile
• Diclofenac Topical - Full Profile
• Pentosan (Joint Pain) - Full Profile
• ARA-290 - Full Profile
• Cartalax - Full Profile

View full Boswellia (AKBA) profile with 3D molecule viewer →